etidronate has been researched along with Aortic Arteritis, Giant Cell in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Excerpt | Relevance | Reference |
---|---|---|
" We used a randomized placebo-controlled design to evaluate the efficacy of one-year cyclical etidronate therapy in preventing bone loss in 83 glucocorticoid-treated patients with rheumatoid arthritis, polymyalgia rheumatica, or giant cell arteritis." | 5.09 | Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study. ( Barton, I; Bonvoisin, B; Cortet, B; Hachulla, E; Roux, C, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mulder, H | 1 |
Struys, A | 1 |
Cortet, B | 1 |
Hachulla, E | 1 |
Barton, I | 1 |
Bonvoisin, B | 1 |
Roux, C | 1 |
2 trials available for etidronate and Aortic Arteritis, Giant Cell
Article | Year |
---|---|
Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Bone Density; Drug Administration Schedule; Etidro | 1994 |
Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Bone Density; Doub | 1999 |